Committee opinion no. 634: Hereditary cancer syndromes and risk assessment

Obstetrics and Gynecology

Volumn 125, Issue 6, 2015, Pages 1538-1543

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER RISK; COWDEN SYNDROME; DISEASE PREDISPOSITION; FAMILIAL CANCER; FAMILY HISTORY; FEMALE GENITAL TRACT CANCER; GENETIC RISK; HEREDITARY CANCER SYNDROME; HEREDITARY NONPOLYPOSIS COLORECTAL CANCER; HUMAN; MEDICAL HISTORY; MEDICAL SPECIALIST; OVARY CANCER; PATIENT REFERRAL; PEUTZ JEGHERS SYNDROME; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; ANAMNESIS; ETHNOLOGY; FEMALE; GENETICS; GYNECOLOGY; NEOPLASTIC SYNDROMES, HEREDITARY; OBSTETRICS; ONSET AGE; PEDIGREE; PROCEDURES;

AGE OF ONSET; FEMALE; GYNECOLOGY; HUMANS; MEDICAL HISTORY TAKING; NEOPLASTIC SYNDROMES, HEREDITARY; OBSTETRICS; PEDIGREE; REFERRAL AND CONSULTATION; RISK ASSESSMENT;

EID: 84929930443     PISSN: 00297844     EISSN: 1873233X     Source Type: Journal    
DOI: 10.1097/01.AOG.0000466373.71146.51     Document Type: Review

References (21)

1. Family history as a risk assessment tool. Committee Opinion No. 478. American College of Obstetricians and Gynecologists. Obstet Gynecol 2011;117:747-50. [PubMed] [Obstetrics & Gynecology]
2. U.S. Surgeon General. My family health portrait. Available at: https://familyhistory.hhs.gov/FHH/html/index.html. Retrieved January 27, 2015.
3. Lu KH, Wood ME, Daniels M, Burke C, Ford J, Kauff ND, et al. American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers. American Society of Clinical Oncology. J Clin Oncol 2014;32:833-40. [PubMed] [Full Text]
4. Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group. Genet Med 2009;11:35-41. [PubMed] [Full Text]
5. American Gastroenterological Association medical position statement: hereditary colorectal cancer and genetic testing. American Gastroenterological Association. Gastro-enterology 2001;121:195-7. [PubMed]
6. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement. U.S. Preventive Services Task Force [published erratum appears in Ann Intern Med 2005;143:547]. Ann Intern Med 2005;143:355-61. [PubMed] [Full Text]
7. Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment. Genet Med 2015;17:70-87. [PubMed]
8. Hereditary breast and ovarian cancer syndrome. ACOG Practice Bulletin No. 103. American College of Obstetricians and Gynecologists. Obstet Gynecol 2009;113:957-66. [PubMed] [Obstetrics & Gynecology]
9. Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications. Curr Opin Obstet Gynecol 2010;22:72-8. [PubMed]
10. Whittemore AS, Gong G, Itnyre J. Prevalence and contribution of BRCA1 mutations in breast cancer and ovarian cancer: results from three U.S. population-based case-control studies of ovarian cancer. Am J Hum Genet 1997;60: 496-504. [PubMed] [Full Text]
11. Antoniou A, Pharoah PD, Narod S, Risch HA, Eyfjord JE, Hopper JL, et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies [published erratum appears in Am J Hum Genet 2003;73:709]. Am J Hum Genet 2003;72: 1117-30. [PubMed] [Full Text]
12. King MC, Marks JH, Mandell JB. Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. New York Breast Cancer Study Group. Science 2003;302:643-6. [PubMed]
13. Lynch syndrome. Practice Bulletin No. 147. American College of Obstetricians and Gynecologists. Obstet Gynecol 2014;124:1042-54. [PubMed] [Obstetrics & Gynecology]
14. Kohlmann W, Gruber SB. Lynch syndrome. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 2014. Available at: http://www. ncbi.nlm.nih.gov/books/NBK1211. Retrieved January 23, 2015.
15. Genetics Home Reference, National Library of Medicine. Li-Fraumeni syndrome. Available at: http://ghr.nlm.nih. gov/condition/li-fraumeni-syndrome. Retrieved January 23, 2015.
16. Varley JM. Germline TP53 mutations and Li-Fraumeni syndrome [published erratum appears in Hum Mutat 2003;21:551]. Hum Mutat 2003;21:313-20. [PubMed] [Full Text]
17. Schneider K, Zelley K, Nichols KE, Garber J. Li-Fraumeni syndrome. In: Pagon RA, Adam MP, Ardinger HH, Bird TD, Dolan CR, Fong CT, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington; 2013. Available at: http://www.ncbi.nlm.nih.gov/books/ NBK1311. Retrieved January 23, 2015.
18. Eng C. PTEN: one gene, many syndromes. Hum Mutat 2003;22:183-98. [PubMed]
19. Nelen MR, Kremer H, Konings IB, Schoute F, van Essen AJ, Koch R, et al. Novel PTEN mutations in patients with Cowden disease: absence of clear genotype-phenotype correlations. Eur J Hum Genet 1999;7:267-73. [PubMed] [Full Text]
20. Eng C. PTEN hamartoma tumor syndrome (PHTS). In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2014. Available at: http://www.ncbi.nlm.nih.gov/books/NBK1488. Retrieved March 25, 2015.
21. McGarrity TJ, Amos CI, Frazier ML, Wei C. Peutz-Jeghers syndrome. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJ, et al, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 2013. Available at: http://www.ncbi.nlm.nih.gov/books/ NBK1266. Retrieved March 25, 2015.